1. Home
  2. OTTR vs ELVN Comparison

OTTR vs ELVN Comparison

Compare OTTR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Otter Tail Corporation

OTTR

Otter Tail Corporation

HOLD

Current Price

$75.31

Market Cap

3.8B

Sector

Utilities

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

SELL

Current Price

$48.41

Market Cap

4.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OTTR
ELVN
Founded
1907
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.2B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
OTTR
ELVN
Price
$75.31
$48.41
Analyst Decision
Hold
Strong Buy
Analyst Count
4
14
Target Price
★ $88.00
$74.33
AVG Volume (30 Days)
212.9K
★ 1.5M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 3.07%
N/A
EPS Growth
N/A
★ 3.17
EPS
★ 2.95
N/A
Revenue
★ $1,299,640,000.00
N/A
Revenue This Year
$0.88
N/A
Revenue Next Year
$1.92
N/A
P/E Ratio
$25.59
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$75.50
$14.79
52 Week High
$95.09
$62.32

Technical Indicators

Market Signals
Indicator
OTTR
ELVN
Relative Strength Index (RSI) 22.58 56.91
Support Level N/A $44.18
Resistance Level $91.02 $52.39
Average True Range (ATR) 2.63 2.31
MACD -1.31 0.99
Stochastic Oscillator 0.00 67.56

Price Performance

Historical Comparison
OTTR
ELVN

About OTTR Otter Tail Corporation

Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: